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Abstract Following unilateral lesion of the primary
motor cortex, the reorganization of callosal projections
from the intact hemisphere to the ipsilesional premotor
cortex (PM) was investigated in 7 adult macaque monkeys,
in absence of treatment (control; n = 4) or treated with
function blocking antibodies against the neurite growth
inhibitory protein Nogo-A (n = 3). After functional
recovery, though incomplete, the tracer biotinylated dex-
tran amine (BDA) was injected in the ipsilesional PM.
Retrogradely labelled neurons were plotted in the intact
hemisphere and their number was normalized with respect
to the volume of the core of BDA injection sites. (1) The
callosal projections to PM in the controls originate mainly
from homotypic PM areas and, but to a somewhat lesser
extent, from the mesial cortex (cingulate and supplemen-
tary motor areas). (2) In the lesioned anti-Nogo-A anti-
body-treated monkeys, the normalized number of callosal
retrogradely labelled neurons was up to several folds
higher than in controls, especially in the homotypic PM
areas. (3) Except one control with a small lesion and a
limited, transient deficit, the anti-Nogo-A antibody-treated
monkeys recovered to nearly baseline levels of perfor-
mance (73–90 %), in contrast to persistent deficits in the
control monkeys. These results are consistent with a
sprouting and/or sparing of callosal axons promoted by the
anti-Nogo-A antibody treatment after lesion of the primary
motor cortex, as compared to untreated monkeys.
Keywords Reorganization  Callosal connectivity 
Lesion  Tract-tracing
Introduction
The motor cortical areas of macaque monkeys comprise
four main distinct regions: the primary motor cortex (M1),
the premotor cortex (PM), the supplementary motor area
(SMA) and the cingulate motor area (CMA). These four
cortical regions have been subdivided further into subareas
on the basis of anatomical and functional criteria. For
instance, the premotor cortex comprises a dorsal (PMd)
area separated from the ventral (PMv) area (e.g. Kurata
1991, 1994a, b; Kurata and Hoffman 1994). The SMA has
been subdivided into a rostral zone (pre-SMA) and a caudal
zone (SMA-proper), based also on anatomical and func-
tional criteria (e.g. Matsuzaka et al. 1992; Matsuzaka and
Tanji 1996; Preuss et al. 1996; Inase et al. 1999; Shima and
Tanji 1998, 2000; Liu et al. 2002; Fuji et al. 2002; Russo
et al. 2002; Akkal et al. 2007; Nakajima et al. 2009). Based
essentially on the topographic distribution of corticospinal
neurons, three distinct subareas have been recognized in
the CMA (Dum and Strick 1991; He et al. 1995). Finally,
M1 exhibits different properties in its caudal versus rostral
portion (e.g. Strick and Preston 1982; Friel et al. 2007;
Rathelot and Strick 2009). In intact monkeys, the
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corticocortical connectivity of the motor cortical areas is
well established, both within the same hemisphere (e.g.
Luppino et al. 1990, 1993, 1999, 2003; Kurata 1991;
Matelli et al. 1998; Tanne´-Garie´py et al. 2002a) and with
the other hemisphere (e.g. Jenny 1979; Rouiller et al. 1994a;
Liu et al. 2002; Marconi et al. 2003; Boussaoud et al. 2005).
The multiplicity of motor cortical areas in primate repre-
sents a basis for a (partial) vicarious substitution of one area
by others in case of a restricted lesion affecting a specific
motor zone. Along this line, it was shown that PM plays a
crucial role in the spontaneous (incomplete) functional
recovery of hand dexterity after M1 lesion (e.g. Liu and
Rouiller 1999; Frost et al. 2003; Dancause et al. 2006), for
instance based on an enhancement of the homolateral
connectivity of PM with the postcentral gyrus as a result of
M1 lesion (Dancause et al. 2005).
The study of Dancause and collaborators (2005) dem-
onstrates that the intra-hemispheric connectivity of a
motor cortical area (PM in the present case) is subjected to
spontaneous and significant changes, such as rewiring, as a
result of M1 lesion. Such rearrangement is most likely, at
least in part, the anatomical support for (incomplete)
spontaneous recovery from the lesion. If this is the case,
one may predict that a treatment enhancing functional
recovery after motor cortical lesion is likely to promote
adaptive changes in corticocortical connectivity. In this
context, the present study aims at testing the hypothesis
that, after a lesion of M1, the callosal connectivity of PM
is modified, possibly preserved and/or enhanced as a result
of a treatment promoting better functional recovery, by
neutralizing the neurite growth inhibitor Nogo-A. Such
intervention has been shown to enhance functional
recovery and sprouting of the corticospinal tract in rats
(see Gonzenbach and Schwab 2008; Schwab 2010 for
review) and in monkeys subjected to spinal cord injury
(Fouad et al. 2004; Freund et al. 2006, 2007, 2009). More
specifically, we hypothesize that after M1 lesion, in the
absence of treatment, there is a limited spontaneous
sprouting of the callosal projections reaching the ipsile-
sional PM. In contrast, the administration of an anti-Nogo-
A antibody may preserve connectivity and/or promote
local sprouting of callosal fibres reaching PM rostral to the
lesioned M1. To test this hypothesis, adult macaque
monkeys were subjected to a unilateral lesion of M1,
subdivided then in a group of monkeys without treatment
and a group of monkeys treated with an anti-Nogo-A
antibody. In both groups of monkeys, after (incomplete)
functional recovery, the anatomical tracer BDA was
injected in the ipsilesional PM to quantify the number of
callosal retrogradely labelled neurons in the opposite
(intact) hemisphere projecting to PM. Although the BDA
injection sites were located mainly in PMd, some sites also
involved PMv. For this reason, we will use below the
common nomenclature PM to designate these two pre-
motor areas. We hypothesize that, after M1 lesion and due
to preservation of connectivity and/or increase in axonal
sprouting, more labelled callosal neurons will be found in
the anti-Nogo-A antibody-treated monkeys than in the
untreated monkeys, after injection of BDA in the ipsile-
sional PM.
Materials and methods
The inter-hemispheric connectivity of PM has been derived
from 8 adult macaque monkeys (Macaca fascicularis; see
Table 1). The experiments were conducted on two groups
of monkeys: (1) four control monkeys (lesion of M1, no
treatment) and (2) four treated monkeys (lesion of M1 and
anti-Nogo-A antibody treatment). In one treated monkey
(Mk-LA), the delivery of anti-Nogo-A antibody had to be
interrupted after 2 weeks instead of the standard treatment
duration of 4 weeks, due to an infection generated by the
subcutaneous catheter. This animal (Mk-LA) was thus
excluded from further analysis, reducing the group of anti-
Nogo-A antibody-treated monkeys to 3 individuals. All
monkeys were subjected to injections of the neuroana-
tomical tracer BDA (biotinylated dextran amine) in PM. In
the present report, the analysis was restricted to the neurons
retrogradely labelled with BDA in the hemisphere opposite
to the injected PM. BDA is generally used for anterograde
tracing with the aim, in the present series of experiments, to
study the efferent projections originating from PM (data
will be reported elsewhere). Nevertheless, BDA was found
to provide retrograde labelling as well, yielding consistent
and reliable data, as seen in previous studies in which
several retrograde tracers, including BDA, were switched
around across cases (Rouiller et al. 1999; Tanne´-Garie´py
et al. 2002a, b; Liu et al. 2002; Morel et al. 2005;
Boussaoud et al. 2005). Based on these previous data
supporting the reliability of BDA for retrograde tracing, the
present analysis was conducted to assess the origin of
callosal projections reaching PM. Table 1 shows a survey
of the parameters of BDA injections in the premotor cortex
and ibotenic acid injections to induce a permanent lesion in
M1. Surgical procedures and animal care were conducted
in accordance with the Guide for the Care and Use of
Laboratory Animals (ISBN 0-309-05377-3; 1996). The
experimental protocol was approved first by the local
(cantonal) ethical committee (surveying animal experi-
mentation). Finally, the experiments were authorized by
the cantonal (Fribourg) and federal (Swiss) veterinary
officers. The present experiments were covered by the
following authorizations: FR 24/95/1; FR 44/92/3; FR
157/01, FR 157/03, FR 157/04, FR 156/04, FR 156/06, FR
157e/06; FR 185-08.
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In the animal facility, monkeys were housed in rooms of
12 m3, in which usually 2–4 monkeys were free to move
and to interact among each other.1 Before daily behavioural
testing in the morning, the animal caretaker transferred the
monkeys to temporary cages, for subsequent transfer to a
primate chair, in which the monkeys were transported to
the behavioural laboratory. The monkeys had free access to
water and were not food deprived. The reward (pellets)
obtained during the behavioural tests was the first daily
access to food. After completion of the behavioural tests,
the monkeys received additional food (fruits and cereals).
The body weight of the animals was monitored on each
working day. In case the body weight dropped by 10 % or
more, the experiment was interrupted until the monkey
regained the lost weight (this criterion for interruption was
not met in the course of the present experiments).
Table 1 Summary of the properties of each monkey included in the study
Monkey groups Untreated Treated with anti-Nogo-A antibody
Mk-GE Mk-
RO
Mk-CE Mk-BI Mk-VA Mk-SL Mk-MO Mk-LAb
Species fasc fasc fasc fasc fasc fasc fasc fasc
Lesion of M1 hand area Yes Yes Yes Yes Yes Yes Yes Yes
Treatment None None None None Anti-
Nogo-A
antibody
Anti-
Nogo-A
antibody
Anti-
Nogo-A
antibody
Anti-
Nogo-A
antibody
Age at time of lesion (rounded 0.5 year) 5 4 4.5 5 5.5 5.5 5.5 5
Weight at time of lesion (kg) 2.8 3.2 3.8 5 4.9 4.6 5.6 2.6
Volume of ibotenic acid injected (lL) 13 18 40 29.74 15.5 18 20 13.5
No. of ICMS sites injected with ibotenic
acid
13 12 21 29 11 11 20 9
Volume of BDA injected (lL) 2.1 4.8 16 7.2 5 10 10.8 2
No. of BDA sites injected 5 6 16 11 5 10 12 5
Hemisphere in which BDA was injecteda LH LH LH LH LH LH LH LH
Time interval between lesion and
beginning of post-lesion ICMS (months)
3.25 5 11 7.3 10.5 16.5 3.2 6.75
Time interval between end of post-lesion
ICMS and BDA injection (days)
17 30 12 27 14 58 75 160
Duration of survival time (days) 29 21 21 22 22 18 21 27
Cortical areas of BDA injections PMd/PMv PMd PMd/PMv PMd/PMv PMd/PMv PMd/PMv PMd/PMv PMd/PMv
Volume of injection site core (in mm3) 23.8 41.4 64.2 83.6 21.1 4.2 106.3 17.8
Total number of callosal-labelled cells 167 89 76 958 927 49 1,805 73
Total volume of lesion (mm3)
Grey matter (motor cortex ? post-central
gyrus)
48.7 14 112.8 20.13 20 78.2 41.8 3.12
Volume of lesion in post-central gyrus
(mm3)
7.6 0 10.1 0 5.8 1.8 0 0
Volume of lesion spread to subcortical
white matter (mm3)
0 0 86.5 0 0 130.6 0 0
Under species, ‘‘fasc’’ is for Macaca fascicularis
Monkey Mk-CE was part of a pilot study (Liu and Rouiller 1999), with the initial aim to generate a large lesion. In subsequent monkeys (Mk-GE,
Mk-LA and MK-VA), the volume of ibotenic acid was reduced to generate a lesion more focused to the M1 hand area. In the monkeys included
later over the 8 years of the study (Mk-RO, Mk-BI, Mk-MO, and Mk-SL), ibotenic acid was injected under propofol anaesthesia (as required by
new ethical guidelines), instead of in the awake state in the preceding monkeys. The volume of ibotenic acid was thus slightly augmented, as
propofol may reduce the excitotoxic effect of ibotenic acid (Snyder et al. 2007)
a Ipsilesional hemisphere (LH = left hemisphere)
b Mk-LA was excluded from further analysis, as the anti-Nogo-A antibody treatment lasted only 2 weeks (instead of 4 in all other treated
animals) and because the lesion turned out to be very small
1 A new Swiss regulation has been introduced in September 2010
requesting now a volume of 45 m3 at least to be given to a group of up
to 5 macaque monkeys.
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The survey of the temporal sequence of the overall
experimental protocol conducted on each monkey is as
follows. (a) The monkeys were subjected to initial
behavioural training to several manual dexterity tasks
during several months (Schmidlin et al. 2011), until
reaching a pre-lesion plateau of performance. The dura-
tion of the pre-lesion behavioural training was quite
variable across monkeys, reflecting different inter-indi-
vidual capabilities to consolidate a wide palette of
manual dexterity tasks. Furthermore, for scheduling rea-
sons, the (stable) pre-lesion plateau phase was prolonged
in some cases to wait for an adequate time widow to
conduct the subsequent, intensive daily pre-lesion ICMS
sessions (see next step). (b) The hand representation in
M1 was identified electrophysiologically based on intra-
cortical microstimulation (ICMS). (c) A permanent lesion
of the hand area in M1 was performed by infusing ib-
otenic acid, immediately followed in the group of treated
monkeys by infusion of anti-Nogo-A antibody during
4 weeks. (d) The daily behavioural assessment of manual
dexterity was pursued during several weeks or months
(depending on the individual time course of recovery: see
Table 1), in order to assess the functional deficit and the
progressive (incomplete) restitution of manual perfor-
mance, until a post-lesion plateau was reached. (e) The
ICMS sessions were repeated at the same cortical sites as
pre-lesion, in order to establish motor map changes
observed post-lesion and possibly related to the extent of
functional recovery (ICMS data reported elsewhere).
(f) To investigate the possible roles played by different
motor cortical areas (e.g. PMd or PMv) in the functional
recovery post-lesion, reversible inactivation sessions were
conducted by infusing muscimol (GABA agonist) at sites
previously established using ICMS (muscimol data
reported elsewhere). (g) The tracer BDA was finally
injected in PM, to establish its post-lesional connectivity,
which is the topic of the present study regarding the
origin of callosal afferents to the ipsilesional PM.
(h) After a survival time (see Table 1) to allow axonal
transport of BDA, the monkeys were killed for histo-
logical evaluation.
The present experimental protocol, described below step
by step in more detail, applies to the group of treated
monkeys (Mk-VA, Mk-SL, Mk-MO, Mk-LA), whereas for
the group of control monkeys (Mk-GE, Mk-RO, Mk-CE
and Mk-BI), the anti-Nogo-A antibody treatment was
omitted. The 7 cases considered for analysis (Mk-GE, Mk-
RO, Mk-CE, Mk-BI, Mk-VA, Mk-MO and Mk-SL) have
already been considered in recent reports dealing with the
influence of the lesion of M1 on the manual performance of
the ipsilesional hand or in relation to adult progenitor cells
transplantation (Kaeser et al. 2010, 2011; Bashir et al.
2012).
Surgery
The monkeys were implanted unilaterally with a chronic,
stainless steel or tecapeek chamber giving access to M1,
the dura mater being, however, left in place (see Schmidlin
et al. 2004 for detail). The monkeys were sedated with i.m.
injection of ketamine (Ketalar, 5 mg/kg) and pre-medi-
cated as previously described, in particular with injection
of the analgesic carprofen (Rymadil, 4 mg/kg, s.c.) to
reduce pain after surgery (Schmidlin et al. 2005; Wannier
et al. 2005; Freund et al. 2006). The surgical intervention
itself was conducted under aseptic conditions and deep
anaesthesia, maintained several hours by i.v. infusion of
propofol (mixture of 1 % propofol and 4 % glucose in
saline, 1 volume of propofol and 2 volumes of glucose
delivered at the rate of 0.1 ml/min/kg). Ketamine was
added to the perfusion solution, as previously reported
(Freund et al. 2007). The surgery was carried out under
continuous monitoring of the following parameters: heart
rate, respiration rate, expired CO2, arterial O2 saturation
and body temperature. After surgery, the animals were
treated with antibiotics (ampicilin 10 %, 30 mg/kg, s.c.)
and analgesics (pills of Rymadil mixed with food) during
several days. The chambers were fixed to the skull with
titanium screws and orthopaedic cement (Palacos). The
inside of the chronic chamber was cleaned daily with
Betadine, and an antibiotic ointment was spread on the
dura mater surface to reduce the risk of infection.
Behavioural assessment: Brinkman box
The monkeys were trained to perform a large palette of
manual dexterity tasks, as previously described in detail
(e.g. Rouiller et al. 1998; Freund et al. 2009; Kaeser
et al. 2010, 2011; Schmidlin et al. 2011; see also http://
www.unifr.ch/neuro/rouiller/motorcontcadre.htm). Our main
behavioural test was based on a modified version of the
Brinkman board task (e.g. Brinkman and Kuypers 1973;
Brinkman 1984), in which the monkeys had to grasp food
pellets from wells using the precision grip (opposition of
thumb and index finger). The behavioural data for all
monkeys subjected to motor cortex lesion will be presented
in a comprehensive manner elsewhere (based on the
complete palette of tests and on a larger populations of
monkeys, including those not subjected to BDA injections
in the premotor cortex). The present report will show
behavioural data only for monkeys subjected to a lesion of
the motor cortex and to BDA injection in the premotor
cortex. In the present report, the behavioural assessment is
focused on a further variation in the modified Brinkman
board task (Schmidlin et al. 2011), consisting of a ‘‘box’’
containing only 20 wells (instead of 50) but confined to a
restricted volume, limiting the movements and orientations
324 Exp Brain Res (2012) 223:321–340
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of the hand to approach the wells (Fig. 1c). The dimensions
of the ‘‘box’’ are 23 cm (length) 9 13 cm (width) 9
10 cm (height). Only one side of the ‘‘box’’ is open to
allow access with the hand to the pellets inside the ‘‘box’’.
The board inside the ‘‘box’’ is made of 10 wells oriented
vertically and 10 wells oriented horizontally. Under visual
control, the monkey had to grasp the food pellets. The total
time (in seconds) needed to empty all 20 wells was mea-
sured (Fig. 2). After several weeks of training, the mon-
keys reached a plateau of hand performance, after which a
pre-lesion performance of reference was established
(Fig. 2), before the motor cortex was electrophysiologi-
cally mapped and lesioned (see below). The behavioural
assessment was continued during the weeks/months post-
lesion, in order first to quantify the deficit of manual
dexterity induced by the lesion of M1 and then to establish
the time course of (incomplete) functional recovery, until a
post-lesion behavioural plateau was reached. As previously
reported (e.g. Kaeser et al. 2010, 2011; Bashir et al. 2012;
Schmidlin et al. 2011), the time course of functional
recovery varied across monkeys, explaining variable time
intervals between the cortical lesion and the onset of the
post-lesion ICMS experiments (see Table 1), in addition to
schedule (seasonal) constraints. Mk-CE is not included in
the behavioural data based on the Brinkman box task
(Fig. 2) because, when the experiment was conducted on
Mk-CE, the Brinkman box test was not introduced yet in
our behavioural palette of manual dexterity tasks. How-
ever, a comparison of the functional recovery observed in
the six monkeys engaged in the Brinkman box task (Fig. 2)
with that derived in Mk-CE from the modified Brinkman
board task is shown (see Fig. 6c and related text in the
results section).
Electrophysiology: intracortical microstimulation
(ICMS)
Electrophysiological intracortical microstimulation (ICMS)
sessions were performed twice, first before lesion in order
to guide the lesion procedure by mapping the M1 hand
representation and, second, several months after the lesion
when the monkeys reached a stable manual performance in
the motor tasks (see e.g. Rouiller et al. 1998; Liu and
Rouiller 1999; Schmidlin et al. 2004; Freund et al. 2006,
2009). A tungsten microelectrode (0.1–1 MX impedance,
FHC Inc, USA.) was used to micro-stimulate the motor
cortex accessible from the chronic chamber, along pene-
trations performed at 1 mm distance from each others (see
e.g. Schmidlin et al. 2004, 2005). Along each electrode
track, ICMS was applied below the surface of the dura at
intervals of 1 mm, along a variable distance depending on
the position of the penetration with respect to the central
sulcus (see Kaeser et al. 2010). The effect of ICMS was
assessed by visual inspection and/or palpation of the body
part (articulation) at which a movement was elicited. The
minimal current (ICMS threshold) producing this move-
ment was determined at each stimulation site. A raw ICMS
map was reconstructed first, showing the position of the
electrode penetrations on the surface of the cerebral cortex
(as shown in Fig. 1d for Mk-BI). In a second step, an
unfolded ICMS map was established, as previously repor-
ted (Kaeser et al. 2010: supplementary Fig. 1; Park et al.
2001, 2004), representing a further basis to guide injections
of ibotenic acid to produce a permanent lesion of M1 tar-
geted mainly on the hand area (pre-lesion ICMS sessions)
and BDA injections in PM (post-lesion ICMS sessions). As
expected, in the hand representation in M1, along most
electrode penetrations performed pre-lesion, the lowest
current (threshold) eliciting movement of the contralateral
digits was below 10 lAmps. In contrast, in PM along
individual electrode penetrations considered for BDA
injections, the lowest thresholds to elicit contralateral digit
movements ranged between 25 and 80 lAmps, with the
exception of an ICMS site with a threshold at 17 lAmps
(the detailed ICMS maps obtained post-lesion will be
reported elsewhere).
Permanent lesion of M1 hand representation
with ibotenic acid
In order to induce a permanent lesion of the motor cortex,
the neurotoxic ibotenic acid (10 lg/ll in phosphate buffer)
was infused using a Hamilton micro-syringe at selected
intracortical microstimulation (ICMS) sites of the hand
area in M1 unilaterally, as previously reported in detail
(Liu and Rouiller 1999; Kaeser et al. 2010, 2011; Bashir
et al. 2012; Peuser et al. 2011). The number of ICMS sites
injected and the total volume of ibotenic acid infused in
M1 were determined based on the extent and shape of the
hand area established for each monkey on the basis of the
ICMS map. As the extent of the hand area varied across
monkeys, the volume of ibotenic acid injection was adap-
ted to this parameter (Table 1). In one monkey (Mk-CE),
performed in the context of a pilot study long time ago (Liu
and Rouiller 1999), a large volume of ibotenic acid was
injected in M1, generating an extensive lesion. For sub-
sequent animals, in order to produce a lesion more focused
to the hand representation in M1, the volumes of ibotenic
acid injected were reduced (Table 1), ranging from 13 to
30 ll depending on the extent of the hand area determined
by ICMS. The parameters of ibotenic acid injections are
indicated for each monkey in Table 1. As a result of ib-
otenic acid infusion, the contralateral hand exhibited after a
few minutes a dramatic flaccid paralysis. The location and
extent of the lesion are shown on lateral views of the left
hemisphere in the four untreated (control) and the three
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anti-Nogo-A antibody-treated monkeys included in the
neuroanatomical analysis (Fig. 1a).
Anti-Nogo-A antibody treatment
As outlined in Table 1, four of the eight monkeys subjected
to unilateral permanent lesion of the motor cortex were
treated with anti-Nogo-A antibody, delivered immediately
after the lesion during four weeks (except in Mk-LA in
which the treatment lasted only 2 weeks and eliminated
from further analysis). The anti-Nogo-A antibody treatment
was similar to that applied to monkeys subjected to spinal
cord injury (Freund et al. 2006, 2007, 2009), except that two
osmotic pumps were implanted instead of one. The tube
326 Exp Brain Res (2012) 223:321–340
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delivering the antibody from one osmotic pump was placed
intrathecally in the cervical cord, whereas the tube of the
second osmotic pump was placed below the dura in the
vicinity of the lesion of M1. The anti-Nogo-A antibody
treatment was tested here for motor cortex lesion in mon-
keys, as it was found to significantly enhance functional
recovery after cortical lesion in rats (Papadopoulos et al.
2002; Emerick et al. 2003; Emerick and Kartje 2004;
Markus et al. 2005; Seymour et al. 2005; Tsai et al. 2007;
Cheatwood et al. 2008; Gillani et al. 2009). Delivery of the
anti-Nogo-A antibody in the cervical cord, in addition to the
cerebral cortex, was motivated by possible enhancement of
sprouting of corticospinal axons originating from PM at
segmental level, in line with evidence for an increase in
functional recovery and sprouting of corticospinal axons
after cervical cord injury in macaques treated with anti-
Nogo-A antibody (Freund et al. 2006, 2007, 2009).
BDA injection and histology
After completion of the post-lesion ICMS investigations
(see Fig. 1d for Mk-BI), reversible inactivation experi-
ments (muscimol infusions) were conducted to investigate
the possible role played by distinct motor cortical areas in
the functional recovery (data to be reported elsewhere).
Depending on the duration of the reversible inactivation
experiments in each monkey, corresponding to a variable
time interval as indicated in Table 1, BDA was injected in
the ipsilesional PM, following a surgical procedure and
anaesthesia protocol as described above. BDA (MW
100000, 10 % in phosphate-buffered saline, Molecular
Probes, Eugene, OR) was injected unilaterally into PM
(mainly in PMd and to a lesser extent in PMv) on the
lesioned hemisphere of the 8 lesioned monkeys (except in
Mk-RO in which the injection was restricted to PMd, as
PMv was not accessible from the implanted chronic
chamber), using a Hamilton micro-syringe, as previously
described (e.g. Rouiller et al. 1994a, b, 1996, 1999, 2003;
Liu et al. 2002; Tanne´-Garie´py et al. 2002a; Boussaoud
et al. 2005; Morel et al. 2005; Cappe et al. 2007, 2009).
PMd and PMv areas on the ipsilesional side were identified
partly based on the ICMS sessions performed pre-lesion
and post-lesion. As illustrated for Mk-BI (Fig. 1d), the
post-lesion ICMS map exhibited two territories, one loca-
ted dorso-rostrally and one ventro-rostrally, most likely
corresponding to PMd and PMv, respectively, as reflected
by the higher thresholds observed than in M1 (see above
for threshold ranges). Sites (or in the vicinity) where ICMS
produced digits and/or hand (wrist) movements were then
selected for BDA injections (purple arrows in Fig. 1d,
pointing to 6 injection sites in PMd and 5 injection sites in
PMv). When the ICMS assessments were less extensive in
PM, the position of PMd and PMv was also estimated
based on their standard (expected) position with respect to
the well-delineated M1 hand area (as derived from
numerous previous studies: e.g. Boussaoud et al. 2005;
Morel et al. 2005). The injections of BDA were preceded
by the reversible inactivation sessions, in which muscimol
was infused in PMd and/or PMv. As a result of muscimol
infusion, there was in most cases a drop of the manual
performance recovered post-lesion, suggesting that the
inactivated areas play a role in the motor control and in the
functional recovery. This is consistent with the idea that the
areas infused with muscimol correspond to PMd and/or
PMv. In most cases, the sites infused with muscimol are the
same loci where BDA was injected at a later time point.
The detailed parameters of BDA injections are given for
each monkey in Table 1. The survival time after BDA
injection ranged from 18 to 29 days, to allow anterograde
transport of the tracer down to the cervical cord, as
assessed in previous experiments (Rouiller et al. 1994a, b,
Fig. 1 a Reconstruction on a lateral view of the left hemisphere in
each monkey of the location and extent of the lesion aimed at the M1
hand representation (red territory) and BDA injection sites (territory
in dark green for the core of the injection site and light green for the
halo), as seen in transparency of the cortical surface. The actual
volume of the lesions and BDA injections sites are given in Fig. 6b
and Table 1. Mk-LA is not shown as it was excluded from the
neuroanatomical analysis (see Table 1). b Photomicrograph of a
typical BDA injection site in PMd and resulting BDA retrogradely
labelled callosal cells in the opposite hemisphere. c View of the
‘‘Brinkman box’’ used for behavioural assessment of manual dexter-
ity, representing a variation in our modified Brinkman board task (see
text). The left picture shows the open facet of the ‘‘box’’ allowing
access to the 20 wells, in which the pellets are placed. The right
picture shows that ‘‘box’’ from above with the monkey’s hand aimed
to a well filled with a pellet to be grasped using the precision grip
between the index finger and the thumb. At the beginning of the test,
the 20 wells are each filled with a pellet. As the top facet of the ‘‘box’’
is transparent, the hand movements are executed under visual control.
The behavioural test was taped with a video camera placed below the
‘‘box’’. d Raw ICMS map established post-lesion in Mk-BI, as it
represented the basis to identify positions where to perform penetra-
tions with the syringe to infuse muscimol in PMd or PMv and then
injections of BDA. Along the axes, ‘‘R’’ is for rostral and ‘‘M’’ is for
medial. The circles represent the positions of electrodes penetrations
for ICMS on the cortical surface, with colour code to represent the
body territory activated at the lowest threshold along the correspond-
ing electrode penetration. The threshold value is given by the size of
the circle in microAmps (see on the right of the ICMS map). Circles
comprising 2 colours are for ICMS electrode penetrations along
which 2 body territories were activated at comparable threshold
values. The purple arrows are for the sites of infusion of muscimol in
PMd or in PMv, which were then used also as sites for BDA
injections. Six sites of BDA injections were selected in PMd and
5 sites in PMv. BDA was injected in PMd and in PMv at sites where
digits were activated by ICMS (yellow circles), or at sites where
ICMS elicited at lowest threshold a wrist movement (red circles). In
the latter case (wrist representation), there was also some ICMS effect
on the digits, but at higher threshold. Note in M1 the presence of a
few ICMS sites where digits movements were elicited at low
intensity, but much fewer than on the pre-lesion ICMS map (not
shown). Note also the presence of numerous non-micro-excitable
sites, typical of the post-lesion ICMS map
b
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1996). Such duration of survival time is also sufficient for
retrograde transport of BDA to the intact hemisphere. The
animals were then killed with an overdose of pentobarbital
sodium (90 mg/kg body weight, i.p.). Transcardiac perfu-
sion with 0.9 % saline (500 ml) was followed by fixative
(paraformaldehyde 4 % in phosphate buffer), and 10, 20,
30 % solutions of sucrose in phosphate buffer. The brains
were placed in a 30 % solution of sucrose (in phosphate
buffer) for cryoprotection during 3–5 days. Frontal sections
(50 lm thick) of the brain were prepared using a cryostat
and collected in five series. BDA staining was revealed in
one series of sections, as previously described (Rouiller
et al. 1994a, b). A second series of sections was Nissl
stained with cresyl violet, whereas a third series of sections
was processed to visualize the marker SMI-32, as previ-
ously described (Liu et al. 2002; Wannier et al. 2005;
Beaud et al. 2008). The two remaining series of sections
were kept in reserve.
Data analysis
Nissl- and SMI-32-stained sections were used to recon-
struct on consecutive sections the position and extent of the
permanent lesion in M1. BDA-stained sections were used
to reconstruct the position and extent of BDA injection
sites in PM. The lesion and the BDA injection sites were
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positioned on a lateral view of the lesioned hemisphere
(Fig. 1a). An individual BDA injection site appears as a
column of about 1–3 mm of diameter. As BDA was
injected at multiple sites adjacent to each other, a com-
posite BDA injection site was obtained, corresponding to a
dense and dark centre zone (‘‘core’’ of the injection site),
surrounded by a less dense zone (‘‘halo’’ of the injection
site; Fig. 1b). The core and ‘‘halo’’ of the composite BDA
injection site are represented for each monkey by the dark
green and light green areas in Fig. 1a, respectively.
Applying a comparable approach as previously described
in detail (see e.g. Pizzimenti et al. 2007; Darling et al.
2009), based on an ad hoc function of the Neurolucida
software (based on the Cavalieri method; Microbrightfield,
Colchester, VT), the volume of the cortical lesion (in mm3)
was extrapolated from the reconstructions of the lesion on
consecutive SMI-32-stained histological sections of the
brain taken every 0.25 mm intervals (see Table 1). The
same procedure was used to determine the volume of the
BDA injections sites on BDA-stained sections, separately
for the core and the halo territories. On the corresponding
histological sections (SMI-32, BDA staining), the lesion
territory, the core of the BDA injection site and the halo of
the BDA injection site were each delineated by tracing
closed contours on their estimated boundaries with differ-
ent colours in Neurolucida. The consecutive sections were
then aligned along the rostro-caudal axis, using the mark
left by a needle inserted through the brain before section-
ing. The Cavalieri estimator was then applied to estimate
the total area and the volume of the territories identified as
different objects. The measurement of volumes (lesion
territory or BDA injection sites) were not corrected for
potential tissue shrinkage, assuming it was most likely
comparable across monkeys as the histological processing
was similar from one animal to the next.
The distribution of retrogradely BDA-labelled neurons
on the opposite hemisphere was plotted using Neurolucida
software, on sections taken at 1 mm interval. Drawings
with plots of labelled neurons were then printed in the form
of pdf files for later processing using the software Corel-
Draw 14 (X4). As previously reported in tracing studies in
which all labelled neurons were counted on the analysed
sections (see e.g. Lavenex et al. 2000; Geuna 2000; Benes
and Lange 2001), stereological technique is not adequate.
Stereology is appropriate when the number of cells to be
counted is so large that samples have to be considered. In
the present study, all labelled neurons were systematically
chartered (as the number of labelled neurons in the intact
hemisphere was relatively low). This approach is consid-
ered as adequate because all samples were analysed using
the same procedure.
To account for variability due to the size of BDA
injection sites and BDA uptake, the number of BDA-
labelled neurons was normalized based on the volume of
the core of the corresponding BDA injection site: the
number of BDA-labelled cells was divided by the volume
of the core of the injection site expressed in mm3.
Figure 1b illustrates a typical BDA injection site in PMd
(top panel) and retrogradely BDA-labelled callosal neurons
in the opposite hemisphere (bottom panel). The parcella-
tion of the cerebral cortex in the intact hemisphere, in
which the labelled neurons were distributed into distinct
cortical areas, was based on criteria previously defined (Liu
et al. 2002; Boussaoud et al. 2005).
Results
The lesion of the motor cortex was targeted to the hand
representation of M1 (as determined on the basis of ICMS
data), which varied in size and precise position across
monkeys. As a result, there was also inter-individual
Fig. 2 Behavioural data showing the manual dexterity of six
monkeys before the lesion (negative days on the abscissa) and post-
lesion (positive days on the abscissa). The day of the lesion (day zero)
is indicated by a vertical line. Each dot value corresponds to the total
time (in seconds) needed by the monkey in a given session to empty
the board containing 20 wells using the contralesional hand (see
Fig. 1c). The median total time pre-lesion is given by the horizontal
dashed line on the left part of each graph. Note the dramatic increase
in total time immediately after the lesion, reflecting the deficit
(increased difficulty to grasp the pellet using the precision grip). The
values saturated at 200 correspond to sessions immediately post-
lesion in which the monkey was unable to complete the task (empty
the 20 wells). Then, there is a progressive recovery of manual
dexterity. The recovery was considered as complete on the day
indicated by the arrow, corresponding to the time point at which the
monkey reached a plateau in the modified Brinkman board task (see
Kaeser et al. 2010, 2011). The median total time at plateau of
recovery is indicated by the horizontal dashed line on the right. In all
monkeys, the post-lesion median total time was significantly longer
than the pre-lesion median total time (p value given for each graph).
The percentage of functional recovery was calculated by dividing the
pre-lesion median total time by the post-lesion median total time at
plateau, multiplied by 100. The percentage of functional recovery is
given in each graph. For the interpretation of the data (see text), the
volume of the cortical lesion in mm3 is indicated also in the graphs for
each monkey. Note that Mk-BI exhibited a peculiar, bimodal
behavioural pattern for this manual dexterity task, present, however,
both pre-lesion and post-lesion: in some daily sessions, the monkey
completed the task quickly (in about 25 s pre-lesion), whereas in other
daily sessions, it took clearly more time (about 70–80 s pre-lesion as
well). As the same bimodal distribution of total times was maintained
post-lesion, it allows comparison of the median values. In line with a
higher median value observed post-lesion for Mk-BI, note that for
each of the two behavioural patterns, the variability across daily
sessions was larger post-lesion as compared to pre-lesion, suggesting
that the monkey was less regular and less comfortable with the task
after the lesion. Moreover, pre-lesion Mk-BI exhibited the ‘‘quick’’
and the ‘‘slow’’ behaviours in equal proportions (50/50 %). After
lesion (at plateau), the ‘‘slow’’ behaviour was more frequently present
(73 % of the daily sessions) than the ‘‘quick’’ behaviour (27 %), also
supporting the strong deficit induced by the lesion
b
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variability in terms of size and location of the lesion, as
represented in transparency of the brain surface in the left
hemisphere of the seven monkeys subjected to a lesion and
included in the analysis (the red areas in Fig. 1a correspond
to the extent of grey matter affected by the lesion).
Preliminary behavioural data
The behavioural consequence of the lesion affecting the
hand area in M1 was a dramatic paralysis of the opposite
hand, within the minutes following the infusion of ibotenic
acid (Liu and Rouiller 1999). In the present study, the
behavioural assessment based on the Brinkman box task
was conducted on six monkeys subjected to a substantial
lesion of M1, followed by a significant deficit of manual
dexterity (Fig. 2). In the group of control monkeys (Mk-
BI, Mk-GE and Mk-RO), two of them showed a consid-
erable increase in the total time needed to empty the 20
wells containing the pellets after the lesion, a deficit that
was long lasting: the post-lesion recovery was clearly
incomplete, representing 48.5 % of the original (pre-
lesion) performance in Mk-BI and 34 % in Mk-GE (Fig. 2
left column). The control monkey Mk-RO exhibited a very
good spontaneous recovery post-lesion, but the volume of
the lesion was clearly smaller than in the other two control
monkeys. In the subgroup of the anti-Nogo-A antibody-
treated monkeys, there was a post-lesion recovery ranging
from 73 to 89.6 % (Fig. 2 right column), although the
volume of the cortical lesion affecting the grey matter was
comparable (Mk-VA; Mk-MO) or even larger (Mk-SL)
than in the two control monkeys (Mk-BI; Mk-GE)
exhibiting clearly incomplete functional recovery (below
50 %). Taking into account that the good spontaneous
recovery observed in Mk-RO is most likely related to a
restricted lesion, the behavioural data for the other five
lesioned monkeys (Fig. 2) provide preliminary evidence
for a better functional recovery in the subgroup of anti-
Nogo-A antibody-treated monkeys (to be confirmed on a
larger number of monkeys and additional behavioural
tests).
Callosal connectivity of PM in the untreated (control)
monkeys
The extent and location of the BDA injections are repre-
sented by the green territories in Fig. 1a. As a result of
BDA injection in PM homolateral to the M1 lesion, the
distribution of retrogradely BDA-labelled callosal neurons
was established in four untreated (control) monkeys, with
typical results illustrated in Fig. 3 (top panel) for Mk-BI
(see also Fig. 6a). PMv, pre-SMA and PMd contained the
highest number of labelled neurons, although labelling was
also substantial in CMA. Clearly fewer labelled neurons
were present in SMA, S1–S2, prefrontal cortex (Pfc) and
M1. In line with BDA injections sites covering a smaller
extent of PMv as compared to PMd, the main region of
origin of the callosal projections in two other control
monkeys originated from the homotypic PMd in the
opposite hemisphere (Fig. 3, bottom panel for Mk-RO;
Mk-GE not shown). In Mk-GE, the other labelled neurons
were distributed in largely comparable amounts in PMv
and pre-SMA; fewer labelled neurons were found in CMA,
SMA and M1. In Mk-RO (Fig. 3; bottom panel), the
additional labelling outside the homotypic PMd was found
in pre-SMA, whereas there was no labelling in Pfc, M1 and
S1–S2. The last control monkey (Mk-CE) was subjected to
a large lesion and BDA was injected in both PMd and PMv
(Fig. 1a). The reconstruction of BDA retrograde labelling
in the intact hemisphere (not shown) exhibited a small
number of labelled callosal neurons (see Fig. 6), most of
them in the homotypic region (PM) and, but to a lesser
extent, in SMA.
Callosal connectivity of PM in the anti-Nogo-A
antibody-treated monkeys
The distribution of BDA-labelled cells resulting from
injection of BDA in the opposite PM, homolateral to the
lesioned M1, assessed in three anti-Nogo-A antibody-
treated monkeys (Mk-LA excluded; see Table 1), is illus-
trated for Mk-MO in Fig. 4. Consistent with BDA injec-
tions covering more PMd than PMv (Fig. 1a), the main
zone of origin of the callosal projections was the homo-
typic PMd (Fig. 4), although substantial labelling was also
present in pre-SMA and PMv. Additional labelled neurons
were observed in SMA and CMA, besides weak labelling
in Pfc, M1 and S1–S2.
In Mk-VA, in which the BDA injections were better
balanced between PMd and PMv, the retrograde labelling
was predominantly found in the homotypic PMd and PMv
(Fig. 5). Other labelled neurons were located in fairly
comparable amounts in pre-SMA, M1, S1–S2 and, but to a
lesser extent, in SMA, Pfc and CMA.
The BDA injections performed in the ipsilesional PM in
another anti-Nogo-A antibody-treated monkey (Mk-SL;
not shown) yielded smaller numbers of labelled neurons. In
the case of Mk-SL, most callosal projections originated
from PMv, although PMd was also involved. Fewer
labelled neurons were located in M1, whereas no labelling
was found in CMA, Pfc, pre-SMA, SMA and S1–S2.
Normalization of the number of labelled callosal
neurons with respect to the volume of injection site
As there was some variability across monkeys with respect
to the sites selected (based on ICMS maps post-lesion) for
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BDA injections, a specific analysis of the distribution of
labelled cells in the distinct subregions of the various motor
cortical areas would be meaningless. For this reason, only
three large cortical zones were considered (Fig. 6a): the
mesial cortex (pre-SMA, SMA and CMA), the premotor
cortex (PM, including few neurons labelled in the pre-
frontal cortex) and the sensorimotor cortex (M1, post-
central gyrus).
Fig. 3 Top panel Frontal sections of the right hemisphere in Mk-BI
(control, untreated monkey), arranged from rostral to caudal, showing
the distribution of retrogradely labelled callosal neurons as a result of
BDA injection in the opposite PM. The number next to each
reconstruction is the serial number of the corresponding histological
section. Scale bar 5 mm. P principal sulcus, AR arcuate sulcus, CE
central sulcus. Bottom panel Frontal sections of the right hemisphere
in Mk-RO (control monkey), arranged from rostral to caudal, showing
the distribution of retrogradely labelled callosal neurons as a result of
BDA injection in the opposite PM. Same conventions as in top panel
Exp Brain Res (2012) 223:321–340 331
123
To account for the inevitable variability across monkeys
due to the size of BDA injection sites (guided by ICMS
maps) and the uptake of the tracer, the callosal data were
normalized based on the volume of the core of the corre-
sponding BDA injection site. The normalization was
obtained by dividing the number of retrogradely labelled
callosal neurons in each cortical area by the volume of the
core of the injection site in mm3. The normalized numbers
of callosal BDA-labelled neurons could thus be better
compared across monkeys, in spite of the individual vari-
ability of the BDA uptake (Fig. 6a). In addition, Fig. 6a
provides an estimate of the contribution of the premotor
area (PMd and PMv), the mesial cortex (pre-SMA, SMA
and CMA) and the sensorimotor cortex (M1, S1 and S2) to
the overall callosal connectivity reaching the ipsilesional
PM. The premotor area also comprises the few labelled
neurons observed in the prefrontal cortex, ranging across
monkeys between 0 and about 2 % of the total number of
labelled cells.
In the group of control monkeys, the majority of callosal
projections reaching the ipsilesional PM originated from
the opposite PM, although a substantial number of pro-
jections came from the mesial cortex (Fig. 6a). The callosal
projections originating from the opposite sensorimotor
cortex (M1, S1 and S2) represented a fairly modest pro-
portion. In the group of anti-Nogo-A antibody-treated
monkeys (n = 3), there were quantitatively higher nor-
malized numbers of callosal-labelled neurons than in the
untreated monkeys (n = 4). There was no overlap of the
normalized total number of BDA-labelled cells in the intact
hemisphere between the 2 groups of monkeys (4 control
versus 3 treated; see Fig. 6a, b), suggesting that the two
groups are different (however, the number of monkeys in
each group is too small to conduct an inter-group statistical
comparison). In more detail, the anti-Nogo-A antibody-
treated monkeys Mk-MO and Mk-SL yielded about twice
more labelling in PM in the intact hemisphere than the
untreated monkey with the highest normalized values (Mk-
Fig. 4 Frontal sections of the right hemisphere in Mk-MO (anti-
Nogo-A antibody-treated monkey), arranged from rostral to caudal,
showing the distribution of retrogradely labelled callosal neurons as a
result of BDA injection in the opposite PM. Scale bar 5 mm. Same
conventions as in Fig. 3
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BI), although the BDA injection site was comparable (Mk-
MO) or even smaller (Mk-SL; see Fig. 1a). In the treated
monkeys Mk-VA, the amount of normalized callosal-
labelled neurons reached a level close to seven times higher
than in the control monkey Mk-BI. The difference was
even larger when comparing the anti-Nogo-A antibody-
treated monkeys Mk-VA, Mk-SL and Mk-MO with the
other three control monkeys Mk-RO, Mk-CE and Mk-GE
(Fig. 6a). Overall, the data presented in Fig. 6a are con-
sistent with an increase in labelled callosal neurons in the
anti-Nogo-A antibody-treated monkeys as compared to
control (untreated) monkeys, all subjected to a lesion in
Fig. 5 Frontal sections of the right hemisphere in Mk-VA (anti-Nogo-A antibody-treated monkey), arranged from rostral to caudal, showing the
distribution of retrogradely labelled callosal neurons as a result of BDA injection in the opposite PM. Same conventions as in Fig. 3
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M1. The difference is mainly due to an increase in labelling
in the homotypic region (PM) of the anti-Nogo-A antibody-
treated monkeys.
Although the volume of BDA injected is a major
parameter influencing the present tracing data, the size of
the M1 lesion may also impact on the retrograde labelling.
To address this issue, the normalized total numbers of
callosal neurons in the intact hemisphere were plotted for
each monkey in a 3D plot, as a function of the volume of
the core of the BDA injection sites and the volume of the
cortical lesion affecting the grey matter (Fig. 6b). In the
anti-Nogo-A antibody-treated monkeys (blue dots in
Fig. 6b), the data indicate an increase in the normalized
total number of labelled callosal neurons (especially in
Fig. 6 a Normalized number of BDA-labelled callosal neurons in the
two groups of monkeys, observed in the intact hemisphere, in each
case and across three main cortical zones (premotor cortex, mesial
cortex and sensorimotor cortex). See text for the description of the
procedure of normalization with respect to the volume of BDA
injection site (core). b 3D plot showing the relationship of the
normalized total number of labelled callosal neurons with the lesion
volume and the volume of the core of the BDA injection sites (see
text). c Two correlation plots illustrate the relationship between the
normalized total number of BDA-labelled cells as a function of lesion
extent (top graph) and between the functional recovery as a function
of lesion extent (bottom graph). The colour code is the same as for
b. In the bottom graph, the functional recovery in percent are the same
values as indicated in Fig. 2, as derived from the Brinkman box task,
except for Mk-CE (empty symbol). Mk-CE did not perform the
Brinkman box task (see text), but the ‘‘modified Brinkman board’’
task. The latter test is generally less challenging than the Brinkman
box task (Schmidlin et al. 2011). Consequently, the functional
recovery value indicated for Mk-CE based on the ‘‘modified
Brinkman board’’ task is higher than what would have been expected
if Mk-CE would have performed the Brinkman box task
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Mk-VA), as compared to the control, untreated monkeys
(see also Fig. 6c). This effect is not due to larger BDA
injection sites in the anti-Nogo-A antibody-treated mon-
keys as their sizes overlap those in the control monkeys
(Fig. 6b). Similarly, the volumes of lesion in the motor
cortex were in a fairly comparable (overlapping) range for
the two groups of monkeys (see also Fig. 6c).
For a more comfortable representation, the normalized
total number of BDA-labelled callosal neurons was plotted
as a function of the volume of the cortical lesion in the
form of a 2D correlative plot (Fig. 6c, top graph), indica-
tive of an absence of correlation between these two
parameters. As an extension of the preliminary behavioural
data shown in Fig. 2, the percent of functional recovery
post-lesion was plotted as a function of the volume of the
cortical lesion (Fig. 6c, bottom graph). These data support
the notion of an enhanced functional recovery in the group
of anti-Nogo-A antibody-treated monkeys (blue symbols),
although one control monkey (Mk-RO) recovered very
well. However, Mk-RO exhibited the smallest lesion and,
even in the absence of treatment, one can expect a prom-
inent functional recovery from a restricted cortical lesion.
Besides the difference between the 2 groups of monkeys
related to the normalized total number of retrogradely
labelled cells in the intact hemisphere, as displayed in
Fig. 6a, one may wonder whether the distribution of
labelled neurons in the 3 main cortical regions (mesial
cortex, premotor cortex and sensorimotor cortex) differs
between the control monkeys and the anti-Nogo-A anti-
body-treated monkeys. To address this question, the num-
bers of labelled neurons in the 3 cortical regions were
cumulated from the different monkeys in each group and a
chi-square statistical test was performed. The result of the
statistical test showed a significantly different distribution
between the control and the anti-Nogo-A antibody-treated
monkeys (p \ 0.001), supporting the notion that the
enhancement of callosal projection in the latter group is not
homogeneous among the three cortical regions, but is
rather focused on the homotypic projection from the intact
PM to the ipsilesional PM.
Discussion
Survey of data
In the present study, we have investigated the reorganiza-
tion of callosal connectivity of the ipsilesional PM fol-
lowing a unilateral lesion of M1 in adult macaques. The
monkeys treated with the anti-Nogo-A antibody exhibited
an enhanced callosal connectivity reaching the ipsilesional
PM, based on the normalized numbers of retrogradely
labelled neurons in the intact hemisphere, in comparison
with the control (untreated) monkeys. As depicted in
Fig. 6a, the enhancement of the callosal connection from
the intact hemisphere to PM induced by the anti-Nogo-A
antibody treatment was essentially present for the homo-
typic projection from PM of the intact hemisphere to the
ipsilesional PM.
Reorganization of corticocortical connectivity
after lesion of M1
In a recent, very extensive and quantitative study,
Dancause et al. (2005) have investigated the rearrangement
of the intra-hemispheric connectivity of PM after lesion of
the homolateral M1 in squirrel monkeys. It was found that
projections originating from PM and directed to M1 in the
intact animal were redirected to the post-central sulcus,
namely to S1. Such intra-hemispheric redirection of axons
was not investigated in the present study, focussed on inter-
hemispheric connections. However, in line with the data of
Dancause et al. (2005), one may speculate that the callosal
axons originating from the intact hemisphere and directed
to the lesioned M1 and perilesional territories may have
been redirected in the lesioned hemisphere, maybe towards
the post-central gyrus as well. This possibility could not be
tested in the present material, as injections in the intact
hemisphere are needed to test this hypothesis (based on
anterograde labelling).
The originality of the present study is essentially that the
reorganization of the connectivity of PM, callosal in the
present case, has been investigated in relation to a treat-
ment (anti-Nogo-A antibody) that enhances fibre growth
and plasticity in the injured and intact brain (Montani et al.
2009; Schwab 2010). As illustrated in Fig. 7 for control
(untreated) monkeys (left panel), the lesion of M1 may be
followed by a limited spontaneous regenerative sprouting
of axons affected by the lesion (blue axon terminal). As
such sprouting may be very limited in distance, injection of
BDA in the ipsilesional PM may not label the corre-
sponding neuron of origin. In contrast, in the anti-Nogo-A
antibody-treated monkeys (Fig. 7, right panel), regenera-
tive sprouting (green axon terminal arising from the blue
axon terminal) may be accompanied by compensatory
sprouting of intact axon terminals originating from a larger
cortical zone in the intact hemisphere (other green axon
terminals in right panel of Fig. 7). Some of them, espe-
cially those originating from PM, are labelled after BDA
injection in the ipsilesional PM. As a result, more retro-
gradely labelled callosal neurons are labelled in the intact
hemisphere than in control monkeys (Fig. 7). As the cal-
losal connectivity is predominantly homotypic, the intact
PM gives rise to more axon terminals in the ipsilesional
PM than projections originating from other cortical areas of
the intact hemisphere (Fig. 7). This interpretation is in line
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with the present observation (Fig. 6a) that the enhancement
of callosal connectivity observed in the anti-Nogo-A anti-
body-treated monkeys (as compared to control monkeys)
was found predominantly for the homotypic projection
from the intact PM to the ipsilesional PM. Furthermore,
although speculative, it may be hypothesized that reactive
events in the lesion and perilesion territories stimulate
sprouting, by the activation of an injury-associated
molecular programme (e.g. Li et al. 2010). Such sprouting
event may be limited in control monkeys, but enhanced in
anti-Nogo-A antibody-treated monkeys, a phenomenon
possibly more effective in territories close by the lesion
(e.g. PM) than in more distant cortical areas (e.g. SMA,
CMA).
As an alternative explanation to enhanced sprouting, one
cannot exclude that the lesion of M1, in particular its con-
sequences during the following hours and days (inflamma-
tion, scar formation, etc.), interrupts callosal axons reaching
the ipsilesional PM, especially if the lesion encroached the
white matter. A possible effect of anti-Nogo-A antibody
treatment could have been to preserve some of the callosal
axons from such damage, resulting in an increase in callosal
connectivity in the treated monkeys. Such mechanism of
preservation might have taken place in Mk-SL, in which the
lesion affected significantly the white matter (subcortical
territory represented in grey in Fig. 1). As indicated in
Table 1, the lesion encroached the white matter in only one
other monkey (Mk-CE), but to a lesser extent than Mk-SL.
Overall, there is no systematic relation between the effect of
anti-Nogo-A antibody treatment on callosal connectivity
and the absence/presence of impact of the lesion on the
white matter (Table 1). However, pro-survival effects of
anti-Nogo-A antibodies or other Nogo-A suppressive
treatments have never been observed up to now in a variety
of different CNS lesion models, in contrast to the well-
documented effects on nerve fibre sprouting and regenera-
tion in spinal cord injury models demonstrating substantial
sprouting (regenerative and compensatory), promoted by
anti-Nogo-A antibody treatment (e.g. Gonzenbach and
Schwab 2008; Fouad et al. 2004; Freund et al. 2007).
Fig. 7 Schematic representation of the pattern of callosal projection
reaching PM in monkeys subjected to a permanent lesion of M1
(black hatched area) and interpretation of the present results. In the
left panel, the control (untreated) monkeys exhibit a modest,
spontaneous regenerative axonal sprouting of the callosal projection
reaching the ipsilesional PM (blue axon terminal). In the right panel,
in contrast, the anti-Nogo-A antibody treatment promotes local
compensatory sprouting of the callosal axons (green axon terminals),
in particular in PM where BDA was injected. In other words, the
results of the present study are consistent with an enhanced number of
callosal neurons in the homotypic PM of the intact hemisphere in the
anti-Nogo-A antibody-treated monkeys as compared to the control
(untreated) monkeys. The horizontal dashed red line represents the
corpus callosum, with the intact hemisphere above and the lesioned
hemisphere below. Neurons in the intact hemisphere send callosal
projections to the lesioned hemisphere, terminating with axonal
boutons (small filled circles). The red circles represent Nogo-A,
inhibiting axonal growth in the adult central nervous system. In the
right panel (treated monkeys), Nogo-A is neutralized with an anti-
Nogo-A antibody. The brown syringe represents the injection of the
tracer BDA in the ipsilesional PM, whereas the brown arrows are for
the retrograde axonal transport of BDA from the injected PM to the
intact hemisphere. As a result, some neurons are retrogradely labelled
with BDA (brown soma in the intact hemisphere). The area ‘‘SMA’’
comprises both pre-SMA and SMA-proper, whereas the area ‘‘CMA’’
includes the three subdivisions of CMA
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Although not excluded, this explanation of preservation
appears less likely therefore at present.
At that step, a relationship between the enhanced cal-
losal connectivity of PM promoted by anti-Nogo-A anti-
body (Fig. 6b) and the improved functional recovery
(Fig. 2) is not demonstrated yet. To demonstrate such an
effect, it would be necessary to transiently inactivate PM
in the intact hemisphere of the anti-Nogo-A antibody-
treated monkeys several months after the lesion and
hopefully obtain a loss of the enhanced functional
recovery of the manual performance. Such reversible
inactivation experiment of the intact PM was not per-
formed in the present study, to not interfere with the
retrograde labelling that was analysed in the intact PM.
Reversible inactivation of PM in the intact hemisphere
after unilateral lesion of M1 was, however, performed
with muscimol infusion in two pilot monkeys not sub-
jected to any treatment in our original study introducing
this model of motor cortex lesion (Liu and Rouiller
1999): in line with the hypothesis of a modest sprouting
of the callosal projections in control monkeys (Fig. 7, left
panel), the reversible inactivation of the contralesional
PM did not affect the incomplete spontaneous recovery of
manual performance in the two untreated monkeys.
Reversible inactivation of the intact PM is an experiment
to be conducted in the future on anti-Nogo-A antibody-
treated monkeys, in which there will be no analysis of
BDA retrograde labelling in the intact PM.
In spite of the lesion of M1, the general pattern of
callosal connectivity of PM found in the present study in
both control and anti-Nogo-A antibody-treated monkeys
remains generally consistent with previous reports in intact
monkeys (Marconi et al. 2003; Boussaoud et al. 2005 for
macaque monkeys; see also Fang et al. 2008 in a prosimian
primate), with a predominance of an origin in the homo-
typic motor cortical area PM, a feature even accentuated as
a result of the anti-Nogo-A antibody treatment. In addition,
in line with these previous studies in intact monkeys, cal-
losal inputs to the ipsilesional PM also originate from other
source areas, such as pre-SMA, CMA, Pfc, SMA and, to a
lesser extent, M1 and S1–S2 (Fig. 6a).
Limitations in the interpretation of the data
First of all, as it is generally the case for non-human pri-
mate studies, the number of animals is limited, mainly for
ethical reasons. Second, as each case was performed one
after the other during several years, there were some
adjustments in the protocol, mainly in relation to the main
objective of the study dealing with the degree of functional
recovery (see Table 1 for details). There is an inevitable
variability across monkeys with respect to the lesion size
and location (Fig. 1a; see Kaeser et al. 2010 for a more
detailed discussion on that issue). While on the experi-
mental point of view, reproducible lesion sizes would be
optimal, on the other hand, the significant variability of
lesion sizes in M1 observed in the present study is more
representative of the even larger variability of cortical
lesions observed in human subjects (see also a recent non-
human primate model of motor cortex lesion, performed
surgically and yielding variable lesion extent as well:
Darling et al. 2009). The present experimental model of
motor cortex lesion in non-human primates, including
significant inter-individual variability in term of lesion
size, may thus be more pertinent for evaluating the trans-
lational value of a treatment towards clinics.
Other parameters are the location and size of BDA
injections, as well as the efficacy of BDA uptake, which
were only in part compensated in the present study by
normalizing the number of retrogradely labelled callosal
neurons by the volume of the injection site (core; see
Fig. 6). Furthermore, in Mk-SL for instance, the lesion
spread largely subcortically in the white matter (see
Fig. 1a), more than in the other monkeys, having possibly
interrupted callosal fibres. As a result, the number of
labelled callosal neurons in Mk-SL was especially low in
spite of a large volume of BDA injected. The normalization
based on dividing the number of labelled cells by the
volume of the injection site (core), as proposed here, rep-
resents only a first approximation, in order to compensate
tentatively for inter-individual variability of tracer uptake.
A linear relationship between the number of labelled cells
and the volume of the injection site (core) is unlikely,
considering that injection sites of similar volume may
spread differently across the grey matter versus white
matter and, in the grey matter, differently across the vari-
ous cortical layers exhibiting variable densities of callosal
terminals. An optimal normalization should thus comprise
a large palette of parameters, some of them being espe-
cially difficult to assess quantitatively. Nevertheless, the
present normalization based on the volume of the injection
site is largely consistent with a normalization based on the
volume of BDA injected (not shown).
Another variable parameter is the duration of survival
time after BDA injection (Table 1). Nevertheless, there
was no systematic difference of survival times between the
2 groups (e.g. short survival times in control monkeys and
long survival times in treated monkeys, or vice versa),
which may explain the increase in retrograde BDA label-
ling in the anti-Nogo-A antibody-treated monkeys. The
absence of effect of survival time duration on BDA
labelling, above a minimal duration required for the
transport of the tracer to cover the desired distance, is in
line with previous studies using BDA (Rouiller et al. 1999;
Tanne´-Garie´py et al. 2002a, b; Liu et al. 2002; Morel et al.
2005; Boussaoud et al. 2005).
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Conclusion
In spite of the above limitations of interpretation, the
present study supports the hypothesis that, after lesion of
M1, the callosal projections reaching the ipsilesional PM
are enhanced after anti-Nogo-A antibody treatment. The
proposed mechanism is an enhancement of sprouting of
callosal axons near their target, promoted by the neutral-
ization of the neurite growth inhibitor Nogo-A (see Fig. 7).
Such a mechanism of axonal sprouting near a lesioned
territory (PM in that case) is comparable to the increased
sprouting of CS axons observed in spinal cord injured
monkeys treated with the anti-Nogo-A antibody, as com-
pared to control antibody-treated monkeys (Fouad et al.
2004; Freund et al. 2006, 2007). Future analyses are needed
to determine whether projections to PM, other than callosal
ones, are also promoted by the anti-Nogo-A antibody
treatment in monkeys with lesion of M1, such as the
thalamocortical projection for instance. Moreover, specific
reversible inactivation experiments will be necessary to
demonstrate that the reorganization of connections pro-
moted by a treatment is indeed the support of enhanced
functional recovery, a demonstration still lacking at that
step for the PM callosal projections reported in the present
study.
As far as the mechanisms of functional recovery from
M1 lesion are concerned, in addition to the possible role
(still to be demonstrated) of connectional reorganization at
cortical level suggested here and in a previous study
(Dancause et al. 2005), plasticity at subcortical level is
likely to play a role as well, for instance the projection of
motor cortical areas preserved by the lesion to the brain-
stem (to mobilize the reticulospinal system for instance)
and, of course, the corticospinal projection system. It was
indeed shown that after lesion of the motor cortex and
lateral premotor cortex, the corticospinal projection origi-
nating from the intact ipsilesional SMA exhibited sprouting
in the cervical cord (McNeal et al. 2010). In the present
study, the infusion of anti-Nogo-A antibody at cervical
level (in addition to delivery at cortical level near the
lesion) may have enhanced such intraspinal axonal
sprouting, a mechanism to test in future functional
investigations.
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